TS
AGN

Twin Securities’s Allergan plc AGN Stock Holding History

Twin Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-109,500
Closed -$25.2M – 25
2016
Q3 		$25.2M Sell
109,500
-53,100
-33% -$13M 4.4% 7
2016
Q2 		$37.6M Sell
162,600
-73,900
-31% -$17M 6.78% 6
2016
Q1 		$63.4M Buy
236,500
+140,000
+145% +$40.1M 7.91% 4
2015
Q4 		$30.2M Buy
96,500
+32,500
+51% +$9.68M 4.94% 8
2015
Q3 		$17.4M Sell
64,000
-29,400
-31% -$9.03M 3.22% 13
2015
Q2 		$27.4M Sell
93,400
-31,100
-25% -$9.28M 5.15% 5
2015
Q1 		$37.1M Sell
124,500
-73,700
-37% -$21M 4.36% 7
2014
Q4 		$51M Buy
198,200
+20,000
+11% +$5M 9.21% 5
2014
Q3 		$43M Sell
178,200
-80,500
-31% -$18M 8.13% 4
2014
Q2 		$57.7M Buy
258,700
+148,700
+135% +$30.8M 9.91% 4
2014
Q1 		$22.6M Buy
+110,000
New +$21.8M 4.11% 9

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Twin Securities's AGN Position: Q2 2020 in Review

Twin Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 667,224 shares — an estimated $118M sold.

Twin Securities first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $118M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Twin Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Twin Securities sold 667,224 Allergan plc shares in Q2 2020, an estimated $118M.
  • Twin Securities first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Twin Securities's Allergan plc position peaked at $118M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Twin Securities's 13F filing for Q2 2020, filed 14 Aug 2020.